Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Stilgenbauer

Showing results (61-70 of 466) with videos related to

Pageof 47
Sort By:
Leukemia & Lymphoma|August 23, 2016
Rapid detection of ATM/p53 function with p27Kip FACS analysis: a novel diagnostic tool for chronic lympocytic leukemia?Viola Meyer-Pannwitt, Daniela Steinbrecher, Stephan Stilgenbauer, et al.
BMC Bioinformatics|October 15, 2024
repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate methodDeyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, et al.
Cancer Treatment Reviews|June 8, 2011
Immune modulatory agents in hematopoietic malignanciesIrina Idler, Nupur Bhattacharya, Hartmut Döhner, et al.
Best Practice & Research. Clinical Haematology|July 13, 2010
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)Thorsten Zenz, Stefan Fröhling, Daniel Mertens, et al.
Nature Reviews. Cancer|December 4, 2009
From pathogenesis to treatment of chronic lymphocytic leukaemiaThorsten Zenz, Daniel Mertens, Ralf Küppers, et al.
BMC Research Notes|July 3, 2025
Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samplesDeyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, et al.
Advanced Biology|August 3, 2023
Aging Associates with Cilium Elongation and Dysfunction in Kidney and PancreasFabian Adametz, Annika Müller, Stephan Stilgenbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2017
Venetoclax in Patients with Previously Treated Chronic Lymphocytic LeukemiaAndrew W Roberts, Stephan Stilgenbauer, John F Seymour, et al.
Blood|July 28, 2010
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoMartina Seiffert, Angela Schulz, Sibylle Ohl, et al.
Haematologica|December 8, 2010
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Angela Schulz, Grischa Toedt, Thorsten Zenz, et al.
Pageof 47

Showing results (61-70 of 466) with videos related to

Sort By:
Pageof 47
Leukemia & Lymphoma|August 23, 2016
Rapid detection of ATM/p53 function with p27Kip FACS analysis: a novel diagnostic tool for chronic lympocytic leukemia?Viola Meyer-Pannwitt, Daniela Steinbrecher, Stephan Stilgenbauer, et al.
BMC Bioinformatics|October 15, 2024
repDilPCR: a tool for automated analysis of qPCR assays by the dilution-replicate methodDeyan Yordanov Yosifov, Michaela Reichenzeller, Stephan Stilgenbauer, et al.
Cancer Treatment Reviews|June 8, 2011
Immune modulatory agents in hematopoietic malignanciesIrina Idler, Nupur Bhattacharya, Hartmut Döhner, et al.
Best Practice & Research. Clinical Haematology|July 13, 2010
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)Thorsten Zenz, Stefan Fröhling, Daniel Mertens, et al.
Nature Reviews. Cancer|December 4, 2009
From pathogenesis to treatment of chronic lymphocytic leukaemiaThorsten Zenz, Daniel Mertens, Ralf Küppers, et al.
BMC Research Notes|July 3, 2025
Genotyping from targeted NGS data based on a small set of SNPs correctly matches patient samplesDeyan Yordanov Yosifov, Christof Schneider, Stephan Stilgenbauer, et al.
Advanced Biology|August 3, 2023
Aging Associates with Cilium Elongation and Dysfunction in Kidney and PancreasFabian Adametz, Annika Müller, Stephan Stilgenbauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 20, 2017
Venetoclax in Patients with Previously Treated Chronic Lymphocytic LeukemiaAndrew W Roberts, Stephan Stilgenbauer, John F Seymour, et al.
Blood|July 28, 2010
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivoMartina Seiffert, Angela Schulz, Sibylle Ohl, et al.
Haematologica|December 8, 2010
Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2Angela Schulz, Grischa Toedt, Thorsten Zenz, et al.
Pageof 47